Ticker > Company >

Suraksha Diagnostic share price

Suraksha Diagnostic Ltd.

  37.66 K   17   9 NSE: SURAKSHA BSE: 544293 SECTOR: Hospital & Healthcare Services

355.05
+8.00 (2.31%)
NSE: 29 Sep 4:00 PM

Price Summary

Today's High

₹ 359.4

Today's Low

₹ 340

52 Week High

₹ 360

52 Week Low

₹ 224.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1849.13 Cr.

Enterprise Value

₹ 1825.55 Cr.

No. of Shares

5.21 Cr.

P/E

50.25

P/B

7.08

Face Value

₹ 2

Div. Yield

0.14 %

Book Value (TTM)

₹  50.17

CASH

₹ 25.24 Cr.

DEBT

₹ 1.66 Cr.

Promoter Holding

49.1 %

EPS (TTM)

₹  7.07

Sales Growth

20.71%

ROE

14.72 %

ROCE

25.57%

Profit Growth

1.86 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year20.71%
3 Year16.54%
5 Year16.52%

Profit Growth

1 Year1.86%
3 Year67.96%
5 Year39.38%

ROE%

1 Year14.72%
3 Year15.44%
5 Year13.69%

ROCE %

1 Year25.57%
3 Year24.96%
5 Year21.56%

Debt/Equity

0.0067

Price to Cash Flow

23.05

Interest Cover Ratio

4.6123

CFO/PAT (5 Yr. Avg.)

2.37338267142136

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 49.10 0.10
Mar 2026 49.10 0.10
Dec 2025 49.00 0.00
Sep 2025 48.98 0.00
Jun 2025 48.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 67.9582742512067% for the Past 3 years.
  • The company has shown a good revenue growth of 16.5360624845793% for the Past 3 years.
  • The company has significantly decreased its debt by 4.1634 Cr.
  • Company has been maintaining healthy ROCE of 24.9584666666667% over the past 3 years.
  • Company is virtually debt free.
  • The Company has been maintaining an effective average operating margins of 28.72332% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -134.8889 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.37338267142136.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.98685844799726.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 70.28 76.26 75.58 78.56 84.09
Total Expenditure 46.44 52.29 52.39 54.75 55.17
Operating Profit 23.84 23.97 23.19 23.81 28.92
Other Income 1.1 0.97 0.99 1.3 1.56
Interest 2.66 2.72 3.1 3.87 3.67
Depreciation 9.15 9.65 10.11 10.69 10.6
Exceptional Items 0 0 0 0 0
Profit Before Tax 13.12 12.57 10.97 10.56 16.21
Tax 3.27 3.21 2.83 3.85 3.63
Profit After Tax 9.85 9.36 8.14 6.71 12.58
Adjusted EPS (Rs) 1.89 1.8 1.56 1.29 2.42

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 223.19 189.99 218.52 249.1 300.68
Total Expenditure 175.11 144.5 146.55 165.84 205.14
Operating Profit 48.09 45.49 71.97 83.26 95.53
Other Income 2.3 3.58 3.65 4.38 4.35
Interest 2.1 9.56 9.57 9.05 13.07
Depreciation 15.09 31.63 32.57 34.73 39.6
Exceptional Items 0 0 -0.78 0 0
Profit Before Tax 33.19 7.87 32.71 43.86 47.22
Tax 9.44 0.68 8.32 10.42 13.15
Net Profit 23.75 7.19 24.38 33.44 34.06
Adjusted EPS (Rs.) 344.22 104.19 353.39 6.42 6.54

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 8.53 8.53 8.53 10.42 10.42
Total Reserves 141.49 148.1 172.34 203.9 239.38
Borrowings 12.28 8.43 5.18 2.88 0.13
Other N/C liabilities 10.36 78.96 76.46 77.7 142.85
Current liabilities 28.08 38.04 39.23 38.21 57.36
Total Liabilities 200.74 282.06 301.75 333.1 450.14
Assets
Net Block 119.31 195.05 211.41 215.15 283.59
Capital WIP 1.09 2.39 1.02 5.32 34.99
Intangible WIP 0 0 0 0.49 1.83
Investments 0.16 0.5 1.16 2.71 6.31
Loans & Advances 9.3 11.42 16.73 29.57 45.45
Other N/C Assets 49.01 5.04 0.68 35.58 14.51
Current Assets 21.86 67.65 70.76 44.27 63.47
Total Assets 200.74 282.06 301.75 333.1 450.14
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 33.19 7.87 32.71 43.86 47.22
Adjustment 15.84 39.65 41.2 41.73 49.24
Changes in Assets & Liabilities -2.27 4.6 -4.08 -12.21 -3.04
Tax Paid -4.44 -7.19 -8.6 -10.58 -13.18
Operating Cash Flow 42.33 44.93 61.23 62.8 80.23
Investing Cash Flow -43.69 -22.04 -35.04 -39.28 -51.25
Financing Cash Flow 1.09 -24.32 -25.83 -24.15 -28.15
Net Cash Flow -0.28 -1.44 0.36 -0.63 0.83

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research Ventura

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY25
Concall Q2FY25
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q2FY25

Company News

Suraksha Diagnostic Stock Price Analysis and Quick Research Report. Is Suraksha Diagnostic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Suraksha Diagnostic. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Suraksha Diagnostic has a PE ratio of 50.2547770700637 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Suraksha Diagnostic has ROA of 8.6978% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Suraksha Diagnostic has a Current ratio of 1.1065.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Suraksha Diagnostic has a ROE of 14.719%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Suraksha Diagnostic has a Debt to Equity ratio of 0.0067 which means that the company has low proportion of debt in its capital.

  • Sales growth: Suraksha Diagnostic has reported revenue growth of 20.7084% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Suraksha Diagnostic for the current financial year is 31.7730430881295%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Suraksha Diagnostic is Rs 0.5 and the yield is 0.1404%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Suraksha Diagnostic is Rs 7.065. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Suraksha Diagnostic in Ticker for free. Also, one can get the intrinsic value of Suraksha Diagnostic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Suraksha Diagnostic FAQs

Q1. What is Suraksha Diagnostic share price today?
Ans: The current share price of Suraksha Diagnostic is Rs 355.05.

Q2. What is the market capitalisation of Suraksha Diagnostic?
Ans: Suraksha Diagnostic has a market capitalisation of Rs 1849.12731279 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Suraksha Diagnostic?
Ans: The PE ratio of Suraksha Diagnostic is 50.2547770700637 and the P/B ratio of Suraksha Diagnostic is 7.07627549342597, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Suraksha Diagnostic share?
Ans: The 52-week high share price of Suraksha Diagnostic is Rs 360, and the 52-week low share price of Suraksha Diagnostic is Rs 224.1.

Q5. Does Suraksha Diagnostic pay dividends?
Ans: Currently, Suraksha Diagnostic pays dividends. Dividend yield of Suraksha Diagnostic is around 0.1404%.

Q6. What are the face value and book value of Suraksha Diagnostic shares?
Ans: The face value of Suraksha Diagnostic shares is Rs 2, while the book value per share of Suraksha Diagnostic is around Rs 50.1747. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Suraksha Diagnostic?
Ans: Suraksha Diagnostic has a total debt of Rs 1.6618 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Suraksha Diagnostic?
Ans: The ROE of Suraksha Diagnostic is 14.719% and ROCE of Suraksha Diagnostic is 25.5667%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Suraksha Diagnostic a good buy for the long term?
Ans: The Suraksha Diagnostic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Suraksha Diagnostic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Suraksha Diagnostic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Suraksha Diagnostic’s financials?
Ans: You can review Suraksha Diagnostic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Suraksha Diagnostic
X